{"entity":{"type":"insider","cik":"0001815851","url":"/insider/0001815851","json_url":"/insider/0001815851.json","name":"Namouni Fouad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2021-10-07","last":"2025-03-07","span_basis":"filed_date"},"name_variants":[{"name":"Namouni Fouad","source":"filing","n_filings":8,"first_seen":"2021-10-07","last_seen":"2025-03-07"}],"transactions":[{"id":4175202,"accession":"0001415889-25-007402","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007402","line_url":"/filing/0001415889-25-007402#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (PRESIDENT, R & D)","role_mark":"O","role_mark_label":"Officer (PRESIDENT, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6489.0,"shares_display":"6,489","price_per_share":88.8,"price_display":"88.80","price_state":"stated","total_value":576223.2,"total_display":"576,223.20","total_whole":"576,223","shares_owned_after":75781.0,"shares_owned_after_display":"75,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":3055027,"accession":"0001415889-24-024776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-024776","line_url":"/filing/0001415889-24-024776#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (PRESIDENT, R & D)","role_mark":"O","role_mark_label":"Officer (PRESIDENT, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3633.0,"shares_display":"3,633","price_per_share":89.32,"price_display":"89.32","price_state":"stated","total_value":324499.56,"total_display":"324,499.56","total_whole":"324,500","shares_owned_after":69070.0,"shares_owned_after_display":"69,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-04","scope":"insider"},{"id":2601417,"accession":"0001415889-24-007554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007554","line_url":"/filing/0001415889-24-007554#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (PRESIDENT, R & D)","role_mark":"O","role_mark_label":"Officer (PRESIDENT, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4377.0,"shares_display":"4,377","price_per_share":90.69,"price_display":"90.69","price_state":"stated","total_value":396950.13,"total_display":"396,950.13","total_whole":"396,950","shares_owned_after":72703.0,"shares_owned_after_display":"72,703","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":8327214,"accession":"0001415889-23-014022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-014022","line_url":"/filing/0001415889-23-014022#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (PRESIDENT, R & D)","role_mark":"O","role_mark_label":"Officer (PRESIDENT, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3769.0,"shares_display":"3,769","price_per_share":48.06,"price_display":"48.06","price_state":"stated","total_value":181138.14,"total_display":"181,138.14","total_whole":"181,138","shares_owned_after":62080.0,"shares_owned_after_display":"62,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-05","scope":"insider"},{"id":8763443,"accession":"0001415889-23-004564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-004564","line_url":"/filing/0001415889-23-004564","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (PRESIDENT, R & D)","role_mark":"O","role_mark_label":"Officer (PRESIDENT, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1948.0,"shares_display":"1,948","price_per_share":45.67601642710472,"price_display":"45.68","price_state":"stated","total_value":88976.88,"total_display":"88,976.88","total_whole":"88,977","shares_owned_after":65912.0,"shares_owned_after_display":"65,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider","n_lines":2},{"id":6934670,"accession":"0001415889-22-010366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-010366","line_url":"/filing/0001415889-22-010366#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (PRESIDENT, R & D)","role_mark":"O","role_mark_label":"Officer (PRESIDENT, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3477.0,"shares_display":"3,477","price_per_share":67.3,"price_display":"67.30","price_state":"stated","total_value":234002.1,"total_display":"234,002.10","total_whole":"234,002","shares_owned_after":52797.0,"shares_owned_after_display":"52,797","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-05","scope":"insider"},{"id":6665767,"accession":"0001415889-22-002738","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-002738","line_url":"/filing/0001415889-22-002738#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (PRESIDENT, R & D)","role_mark":"O","role_mark_label":"Officer (PRESIDENT, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PRESIDENT, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1047.0,"shares_display":"1,047","price_per_share":56.19,"price_display":"56.19","price_state":"stated","total_value":58830.93,"total_display":"58,830.93","total_whole":"58,831","shares_owned_after":56274.0,"shares_owned_after_display":"56,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":4859754,"accession":"0001179110-21-009297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-009297","line_url":"/filing/0001179110-21-009297#line-1","is_derivative":false,"issuer_cik":"0001597264","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001597264","owner_cik":"0001815851","owner_name":"Namouni Fouad","owner_display_name":"Namouni Fouad","owner_url":"/insider/0001815851","role":"Officer (President, R & D)","role_mark":"O","role_mark_label":"Officer (President, R & D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R & D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3241.0,"shares_display":"3,241","price_per_share":98.18,"price_display":"98.18","price_state":"stated","total_value":318201.38,"total_display":"318,201.38","total_whole":"318,201","shares_owned_after":42321.0,"shares_owned_after_display":"42,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Officer (PRESIDENT, R & D)","n_filings":8,"first_seen":"2021-10-07","last_seen":"2025-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001815851","retrieved_at":"2026-08-25T10:00:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}